Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating Costs and Expenses:
General and administrative	$ 1,933	$ 2,201
Research and development	3,459	2,977
Total Operating Costs and Expenses	5,392	5,178
Loss from Operations	(5,392)	(5,178)
Other Income:
Foreign currency exchange (loss) gain	(1)	6
Interest income	228	364
Total Other Income	227	370
Net Loss before income taxes	(5,165)	(4,808)
Income tax benefit		330
Net Loss Attributable to Common Stockholders	$ (5,165)	$ (4,478)
Net Loss Per Share - Basic (in dollars per share)	$ (0.30)	$ (0.30)
Net Loss Per Share - Dilutive (in dollars per share)	$ (0.30)	$ (0.30)
Weighted average number of shares outstanding during the period - Basic (in shares)	17,148,049	15,124,061
Weighted average number of shares outstanding during the period - dilutive (in shares)	17,148,049	15,124,061
Net Loss	$ (5,165)	$ (4,478)
(Loss) gain (loss) on foreign currency translation	(569)	374
Total comprehensive loss	$ (5,734)	$ (4,104)